← Zurück zur Übersicht
Maplight Therapeutics, Inc.
Gemeldet als: MAPLIGHT THERAPEUTICS, INC.
Käufe
6
65.535.496 USD
Verkäufe
52
12.711.420 USD
Netto (Käufe − Verkäufe)
52.824.076 USD
Beteiligte Insider
8
58 Transaktion(en)
| Datum | Insider | Position | Art | Volumen | Preis | Stückzahl |
|---|---|---|---|---|---|---|
| 15.10.2026 | Christopher A. Kroeger
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 595.423,28 USD | 8,08 USD | 73.691 |
| 15.10.2026 | Jonathan Gillis
CAO and Interim CFO
|
CAO and Interim CFO | Verkauf | 82.149,36 USD | 8,08 USD | 10.167 |
| 15.10.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 93.025,04 USD | 8,08 USD | 11.513 |
| 15.10.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 72.881,60 USD | 8,08 USD | 9.020 |
| 15.10.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 124.068,40 USD | 8,08 USD | 15.355 |
| 15.10.2026 | Anatol Kreitzer
Chief Discovery Officer
|
Chief Discovery Officer | Verkauf | 96.024,32 USD | 7,84 USD | 12.248 |
| 16.09.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 192.660,03 USD | 11,67 USD | 16.509 |
| 14.08.2026 | Catalyst4, Inc.
10% Owner
|
10% Owner | Kauf | 50.072.000,00 USD | 11,38 USD | 4.400.000 |
| 03.08.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 276.908,28 USD | 12,54 USD | 22.082 |
| 30.07.2026 | Catalyst4, Inc.
10% Owner
|
10% Owner | Kauf | 13.000.000,00 USD | 13,00 USD | 1.000.000 |
| 29.07.2026 | Catalyst4, Inc.
10% Owner
|
10% Owner | Kauf | 37.890,00 USD | 12,63 USD | 3.000 |
| 28.07.2026 | Catalyst4, Inc.
10% Owner
|
10% Owner | Kauf | 761.392,91 USD | 11,69 USD | 65.137 |
| 28.07.2026 | Catalyst4, Inc.
10% Owner
|
10% Owner | Kauf | 1.515.510,86 USD | 10,74 USD | 141.088 |
| 28.07.2026 | Troy Cox
Director
|
Director | Kauf | 148.702,40 USD | 9,52 USD | 15.620 |
| 17.07.2026 | Jonathan Gillis
CAO and Interim CFO
|
CAO and Interim CFO | Verkauf | 34.353,00 USD | 38,17 USD | 900 |
| 17.07.2026 | Jonathan Gillis
CAO and Interim CFO
|
CAO and Interim CFO | Verkauf | 638.204,09 USD | 37,61 USD | 16.969 |
| 17.07.2026 | Jonathan Gillis
CAO and Interim CFO
|
CAO and Interim CFO | Verkauf | 21.906,00 USD | 36,51 USD | 600 |
| 17.07.2026 | Anatol Kreitzer
Chief Discovery Officer
|
Chief Discovery Officer | Verkauf | 7.678,00 USD | 38,39 USD | 200 |
| 17.07.2026 | Anatol Kreitzer
Chief Discovery Officer
|
Chief Discovery Officer | Verkauf | 533.078,00 USD | 37,70 USD | 14.140 |
| 17.07.2026 | Anatol Kreitzer
Chief Discovery Officer
|
Chief Discovery Officer | Verkauf | 104.962,65 USD | 37,05 USD | 2.833 |
| 17.07.2026 | Christopher A. Kroeger
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 635.924,10 USD | 37,90 USD | 16.779 |
| 17.07.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 78.718,30 USD | 37,90 USD | 2.077 |
| 17.07.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 42.827,00 USD | 37,90 USD | 1.130 |
| 17.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 138.562,40 USD | 37,90 USD | 3.656 |
| 16.07.2026 | Jonathan Gillis
CAO and Interim CFO
|
CAO and Interim CFO | Verkauf | 55.261,44 USD | 37,44 USD | 1.476 |
| 16.07.2026 | Jonathan Gillis
CAO and Interim CFO
|
CAO and Interim CFO | Verkauf | 255.850,14 USD | 36,66 USD | 6.979 |
| 16.07.2026 | Anatol Kreitzer
Chief Discovery Officer
|
Chief Discovery Officer | Verkauf | 59.604,48 USD | 37,44 USD | 1.592 |
| 16.07.2026 | Anatol Kreitzer
Chief Discovery Officer
|
Chief Discovery Officer | Verkauf | 273.630,24 USD | 36,66 USD | 7.464 |
| 16.07.2026 | Christopher A. Kroeger
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 3.492,32 USD | 37,96 USD | 92 |
| 16.07.2026 | Christopher A. Kroeger
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.046.670,66 USD | 37,26 USD | 28.091 |
| 16.07.2026 | Christopher A. Kroeger
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.491.177,54 USD | 36,46 USD | 40.899 |
| 16.07.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 455,52 USD | 37,96 USD | 12 |
| 16.07.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 131.378,76 USD | 37,26 USD | 3.526 |
| 16.07.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 182.578,05 USD | 36,45 USD | 5.009 |
| 16.07.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 417,56 USD | 37,96 USD | 11 |
| 16.07.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 124.113,06 USD | 37,26 USD | 3.331 |
| 16.07.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 174.085,20 USD | 36,45 USD | 4.776 |
| 16.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 721,24 USD | 37,96 USD | 19 |
| 16.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 218.529,90 USD | 37,26 USD | 5.865 |
| 16.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 334.082,98 USD | 36,46 USD | 9.163 |
| 15.07.2026 | Jonathan Gillis
CAO and Interim CFO
|
CAO and Interim CFO | Verkauf | 173.581,06 USD | 36,94 USD | 4.699 |
| 15.07.2026 | Jonathan Gillis
CAO and Interim CFO
|
CAO and Interim CFO | Verkauf | 193.512,28 USD | 36,13 USD | 5.356 |
| 15.07.2026 | Anatol Kreitzer
Chief Discovery Officer
|
Chief Discovery Officer | Verkauf | 166.599,40 USD | 36,94 USD | 4.510 |
| 15.07.2026 | Anatol Kreitzer
Chief Discovery Officer
|
Chief Discovery Officer | Verkauf | 200.340,85 USD | 36,13 USD | 5.545 |
| 15.07.2026 | Christopher A. Kroeger
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 3.378,60 USD | 37,54 USD | 90 |
| 15.07.2026 | Christopher A. Kroeger
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 1.580.878,62 USD | 36,99 USD | 42.738 |
| 15.07.2026 | Christopher A. Kroeger
Chief Executive Officer / Director
|
Chief Executive Officer / Director | Verkauf | 682.200,00 USD | 36,00 USD | 18.950 |
| 15.07.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 450,48 USD | 37,54 USD | 12 |
| 15.07.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 199.487,07 USD | 36,99 USD | 5.393 |
| 15.07.2026 | James Woodruff Lillie
Chief Scientific Officer
|
Chief Scientific Officer | Verkauf | 80.568,00 USD | 36,00 USD | 2.238 |
| 15.07.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 375,40 USD | 37,54 USD | 10 |
| 15.07.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 188.759,97 USD | 36,99 USD | 5.103 |
| 15.07.2026 | Kristopher Hanson
General Counsel
|
General Counsel | Verkauf | 77.292,00 USD | 36,00 USD | 2.147 |
| 15.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 675,72 USD | 37,54 USD | 18 |
| 15.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 331.874,28 USD | 36,99 USD | 8.972 |
| 15.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 160.740,00 USD | 36,00 USD | 4.465 |
| 15.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 290.578,80 USD | 37,04 USD | 7.845 |
| 15.07.2026 | Erin Pennock Foff
Chief Medical Officer
|
Chief Medical Officer | Verkauf | 258.724,80 USD | 36,16 USD | 7.155 |
Transaktionen im Zeitverlauf
Kauf
Verkauf
Blasengröße = Volumen
Punkt = Transaktion · Position auf der Y-Achse = Ø-Preis je Aktie · Fläche = Transaktionsvolumen. Für Details auf einen Punkt tippen oder mit der Maus darüberfahren.